Clinical Serum-Anchored Computational Design Pipeline for a Broad-Spectrum Influenza Multi-Epitope mRNA Vaccine
Biology · 19.02.2026 · 15 (4) · 357
DOI: 10.3390/biology15040357 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biology, online erschienen am 19.02.2026. Verfasst von Lifang Yuan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Infection Immunity and Inflammation, School of Basic Medical Sciences, Shenzhen University Medical School, She…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Natural Science Foundation Project, CAMS Innovation Fund for Medical Sciences, Sanming Project of Medicine in Shenzhen Nanshan.
Abstract (Originalsprache)
Influenza’s pandemic threat is driven by antigenic drift, which limits the efficacy of conventional vaccines. To address this challenge, we established a clinical serum-anchored computational design pipeline for a broad-spectrum multi-epitope mRNA vaccine (MEMV), bridging the gap between pure in silico design and clinical applicability. Using 36 longitudinal sera (d0/d28/d365) from 12 well-characterized human cohorts (6 vaccine recipients and 6 influenza patients) and high-density antibody-peptide microarrays, we empirically identified 12 immunodominant B-cell linear epitopes from the nucleoprotein (NP) of influenza A (H1N1/H3N2) and B viruses. These experimentally validated epitopes were combined with in silico-predicted conserved helper T-lymphocyte (HTL)/cytotoxic T-lymphocyte (CTL) epitopes (from NP/HA/NA) to construct MEMVs candidates, ensuring high antigenicity, non-toxicity, and 95.63% global HLA coverage. Molecular docking and 100 ns molecular dynamics (MD) simulations confirmed favorable conformational compatibility between MEMVs and Toll-like receptor 3 (TLR3) in silico immunization via C-ImmSim predicted robust B/T-cell responses and protective cytokine (IFN-γ/IL-10) production. Collectively, this pipeline shortens the preliminary design cycle for influenza vaccines, provides a standard epitope-combination strategy, and offers direct targets for follow-up in vitro/in vivo experiments.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Infection Immunity and Inflammation, School of Basic Medical Sciences, Shenzhen University Medical School, Shenzhen University, Shenzhen 518060, China.
- Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, National-Regional Key Technology Engineering Laboratory for Medical Ultrasound, School of Biomedical Engineering, Shenzhen University Medical…
- School of Public Health (Shenzhen), Shenzhen Key Laboratory of Pathogenic Microbes and Biosafety, Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China.
- Department of Pathogenic Biology and Immunology, School of Basic Medical Science, Xiangnan University, Chenzhou 423000, Hunan, China.
- Shenzhen Digital Life Institute, Shenzhen 518000, Guangdong, China.
- Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180, China.
ORCID-Profile: Mingchen Yan, Huanle Luo, Yuelong Shu, Yongkun Chen
Förderung
- Beijing Natural Science Foundation Project
- CAMS Innovation Fund for Medical Sciences
- Sanming Project of Medicine in Shenzhen Nanshan
- Shenzhen Science and Technology Program
- Science and Technology Projects in Guangzhou
- Guangdong Basic and Applied Basic Research Foundation
- Shenzhen Medical Research Fund
- Guangdong Provincial Science and Technology Program
Zitieren
APA
Yuan, L., Ouyang, Z., Zhao, Y., Bi, R., Wu, Y., Li, X., Li, Y., Song, J., Li, W., Yan, M., Wen, S., Luo, H., Bai, T., Shu, Y., & Chen, Y. (2026). Clinical Serum-Anchored Computational Design Pipeline for a Broad-Spectrum Influenza Multi-Epitope mRNA Vaccine. Biology, 15(4), 357. https://doi.org/10.3390/biology15040357
Vancouver
Yuan L, Ouyang Z, Zhao Y, Bi R, Wu Y, Li X, et al. Clinical Serum-Anchored Computational Design Pipeline for a Broad-Spectrum Influenza Multi-Epitope mRNA Vaccine. Biology. 2026;15(4):357. doi:10.3390/biology15040357
BibTeX
@article{Yuan2026,
author = {Yuan, Lifang and Ouyang, Zhiyao and Zhao, Yifan and Bi, Rongjun and Wu, Yanjing and Li, Xu and Li, Yingrui and Song, Jiaping and Li, Wei and Yan, Mingchen and Wen, Simin and Luo, Huanle and Bai, Tian and Shu, Yuelong and Chen, Yongkun},
title = {Clinical Serum-Anchored Computational Design Pipeline for a Broad-Spectrum Influenza Multi-Epitope mRNA Vaccine},
journal = {Biology},
year = {2026},
volume = {15},
number = {4},
pages = {357},
doi = {10.3390/biology15040357}
}
EUVIMED